Lung Injury Global Clinical Trials Review, H1, 2012

GlobalData, April 2012, Pages: 88

Lung Injury Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012" provides data on the Lung Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lung Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Lung Injury Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Lung Injury , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Lung Injury
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Lung Injury
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Lung Injury Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Altor BioScience Corporation
Clinical Trial Overview of Altor BioScience Corporation
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Ono Pharmaceutical Co., Ltd.
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd.
Octapharma AG
Clinical Trial Overview of Octapharma AG
LEO Pharma A/S
Clinical Trial Overview of LEO Pharma A/S
Broncus Technologies, Inc.
Clinical Trial Overview of Broncus Technologies, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Policlinico Hospital
Clinical Trial Overview of Policlinico Hospital
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Vanderbilt University
Clinical Trial Overview of Vanderbilt University
Boston Medical Center
Clinical Trial Overview of Boston Medical Center
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
University of Oklahoma
Clinical Trial Overview of University of Oklahoma
University of Tennessee
Clinical Trial Overview of University of Tennessee
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
Changhai Hospital
Clinical Trial Overview of Changhai Hospital
Dresden University of Technology
Clinical Trial Overview of Dresden University of Technology
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Birmingham
Clinical Trial Overview of The University of Birmingham
Chi Mei Medical Center
Clinical Trial Overview of Chi Mei Medical Center
Tianjin University of Traditional Chinese Medicine
Clinical Trial Overview of Tianjin University of Traditional Chinese Medicine
Università degli Studi dell'Insubria
Clinical Trial Overview of Università degli Studi dell'Insubria
UNIVERSITY HOSPITAL, CLERMONT-FERRAND
Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND
Zhongshan Hospital
Clinical Trial Overview of Zhongshan Hospital
Tongji university
Clinical Trial Overview of Tongji university
Penn State University
Clinical Trial Overview of Penn State University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Lung Injury Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2012-
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Lung Injury Therapeutics Clinical Trials, BRIC Countries, 2012-
Lung Injury Therapeutics Clinical Trials, G7 Countries, 2012-
Lung Injury Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Clinical Trials, E7 Countries, 2012-
Lung Injury Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Lung Injury Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Broncus Technologies, Inc., 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Policlinico Hospital, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tennessee, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Changhai Hospital, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Birmingham, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Chi Mei Medical Center, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tianjin University of Traditional Chinese Medicine, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Università degli Studi dell'Insubria, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by UNIVERSITY HOSPITAL, CLERMONT-FERRAND, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhongshan Hospital, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tongji university, 2012-
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012-

List of Figures
Lung Injury Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Lung Injury Therapeutics Clinical Trials, G7 Countries (%), 2012-
Lung Injury Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Clinical Trials, E7 Countries (%), 2012-
Lung Injury Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Lung Injury Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Lung Injury Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Acute Lung Injury Global Clinical Trials Review, H2, 2012
• Acute Lung Injury Global Clinical Trials Review, H2, 2011
• Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2012
• Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012
• Cholangitis Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Otitis Media Global Clinical Trials Review, H2, 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Keratitis Global Clinical Trials Review, H2, 2012